Elimination of Inflammatory Mediators by Hemofiltration

Andreasson S. , Goethberg S. , Berggren H. , Bengtsson A. , Eriksson E. , Risberg B. . Hemofiltration modifies complement activation after extracorporeal circulation in infants. Ann Thorac Surg 1993; 56: 1515–7.

Bellomo R. , Tippint P. , Boyce N. . Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21: 522–6.

Beutler B. . Endotoxin, tumor necrosis factor, and related mediators. New Horizons 1993; V. 3–12

Bone R.C. . The pathogenesis of sepsis. Ann Int Med 1991; 115: 457–69.

Coraim F. , Trubel W. , Ebermann R. , Werner T. . Isolation of low-molecular-weight peptides in hemofiltrated patients with cardiogenic shock: a new aspect of myocardial depressant substances. Contrib Nephrol 1991; 93: 237–40.

Dinarello C.A. , Lonnemann G. , Maxwell R. , Shaldon S. . Ultrafiltration to reject human interleukin-1-inducing substances derived from bacterial cultures. J Clin Microbiol 1987; 25: 1233–8.

Garzia F. , Todor R. , Scalea T. . Continuous arteriovenous hemofiltration countercurrent dialysis (CAVH-D) in acute respiratory failure (ARDS). J Trauma 1991 31: 1277–85.

Giroir B.P. . Mediators of septic shock. New approaches for interrupting the endogenous inflammatory cascade. Crit Care Med 1993; 21: 780–9.

Gomez A. , Wang R. , Unruh H. . Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990; 73: 671–85.

Grootendorst A.F. , van Bommel E.F.H. , van der Hoven B. , van Leengoed L.A. , van Osta A.L. . High volume hemofiltration improves right ventricular function in endotoxininduced shock in the pig. Intensive Care Med 1992; 18: 235–40.

Grootendorst A.F. , van Bommel E.F.H. , van Leengoed LAMG , van Zanten A.R.H. , Huipen H.J.C. , Groeneveld A.B.J. . Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 1993; 8: 161–9.

Hallström S. , Bernhardt E. , Müller U. . A cardiodepressant factor (CDF) isolated from hemofiltrates of patients and/or in cardiogenic shock blocks calcium inward current in cardiomyocytes (Abstract). Shock 1994; 2: S15.

Hallström S. , Koidl B. , Müller U. , Werdan K. , Schlag G. . A cardiodepressant factor isolated from blood blocks Ca current in cardiomyocytes. Am J Physiol 1991; 260: H869.

Heidemann S. , Ofenstein J. , Sarnaik A. . Efficacy of continuous arteriovenous hemofiltration (CAVH) in endotoxic shock (Abstract). Crit Care Med 1993; 21: S159.

Hoffman J.N. , Deppisch R. , Faist E. , Hartl W.H. , Jochum M. , Inthorn D. . Hemofiltration in human sepsis. Evidence for elimination of immunomodulatory substances. Surg Forum 1994; XLV; 69–71.

Hoffmann J.N. , Faist E. , Deppisch R. , Inthorn D. . Septic ultrafiltrate enhances TNF alpha production in endotoxin stimulated human mononuclear cells (PBMC) and down-regulates lymphocyte function (Abstract). Intensive Care Med 1994; 20(suppl. 1): S73.

Kaiser J.P. , Götze O. , Oppermann M. . Hemofiltration but not hemodialysis leads to an impressive reduction of factor D in uremia. Blood Purif (in press).

Lee P.A. , Matson J.R. , Pryor R.W. , Hinshaw B.L. . Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med 1993; 21: 914–24.

Lonnemann G. , Schindler R. , Dinarello C.A. , Koch K.M. . Removal of circulating cytokines by hemodialysis membranes in vitro. In: Host defense dysfunction in trauma, shock and sepsis. Faist E. , Meaking J.E. , Schildberg F.W. (eds), 1993; 613–23. Berlin Heidelberg New York: Springer.

MacKenzie S.J. , Nimmo G.R. , Armstrong I.R. , Grant I.S. . The hemodynamic effects of intermittent hemofiltration in critically ill patients. Intensive Care Med 1991; 17: 346–9.

Millar A.B. , Armstrong L. , van der Linden J. . Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass. Ann Thorac Surg 1994; 56: 1499–502.

Parrillo Je , Burch C. , Shelhamer J.H. , Parker M.M. , Natanson C. , Schuette W. . A circulating myocardial depressant substance in human with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor which depressed in vitro myocardial cell performance. J Clin Invest 1985; 76: 1539–53.

Schetz M. , Gasthuisberg U.Z. . Removal of cytokines in septic patients using continuous veno-venous hemodiafiltration (letter). Crit Care Med 1994; 22: 715.

Staubach K.H. , Rau H.G. , Hohlbach G. , Schildberg F.W. . Continuous arterio-venous hemofiltration (CAVH) in shock - a new strategy to lower eicosanoids. Artif Organs 1987; 11: 336 (Abstract)

Staubach K.H. , Rau H.G. , Kooistra A. , Schardey H.M. , Hohlbach G. , Schildberg F.W. . Can hemofiltration increase survival time in acute endotoxemia-a porcine shock model. Prog Clin Biol Res 1989; 308: 821–4.

Stein B. , Pfenninger E. , Grünert A. , Schmitz J.E. , Hudde M. . Influence of continuous hemofiltration on hemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 1990; 16: 494–9.

Storck M. , Hartl W.H. , Zimmerer E. , Inthorn D. . Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure. Lancet 1991; 337: 452–5.

Tonnesen E. , Hansen M.B. , Höhndorf K. . Cytokines in plasma and ultrafiltrate during continuous arteriovenous hemofiltration. Anaesth Intens Care 1993; 21: 752–8.

Vanholder R. , Van Haecke E. , Veys N. , Ringoir S. . Endotoxin transfer through dialysis membranes: smallversus large-pore membranes. Nephrol Dial Transplant 1992; 7: 333–9.